Pleiotropic Loci for Cannabis Use Disorder Severity in Multi-Ancestry High-Risk Populations
Abstract
Cannabis use disorder (CUD) is common and has in part a genetic basis. The risk factors underlying its development likely involve multiple genes that are polygenetic and interact with each other and the environment to ultimately lead to the disorder. Co-morbidity and genetic correlations have been identified between CUD and other disorders and traits in select populations primarily of European descent. If two or more traits, such as CUD and another disorder, are affected by the same genetic locus, they are said to be pleiotropic. The present study aimed to identify specific pleiotropic loci for the severity level of CUD in three high-risk population cohorts: American Indians (AI), Mexican Americans (MA), and European Americans (EA). Using a previously developed computational method based on a machine learning technique, we leveraged the entire GWAS catalog and identified 114, 119, and 165 potentially pleiotropic variants for CUD severity in AI, MA, and EA respectively. Ten pleiotropic loci were shared between the cohorts although the exact variants from each cohort differed. While majority of the pleiotropic genes were distinct in each cohort, they converged on numerous enriched biological pathways. The gene ontology terms associated with the pleiotropic genes were predominately related to synaptic functions and neurodevelopment. Notable pathways included Wnt/{beta}-catenin signaling, lipoprotein assembly, response to UV radiation, and components of the complement system. The pleiotropic genes were the most significantly differentially expressed in frontal cortex and coronary artery, up-regulated in adipose tissue, and down-regulated in testis, prostate, and ovary. They were significantly up-regulated in most brain tissues but were down-regulated in the cerebellum and hypothalamus. Our study is the first to attempt a large-scale pleiotropy detection scan for CUD severity. Our findings suggest that the different population cohorts may have distinct genetic factors for CUD, however they share pleiotropic genes from underlying pathways related to Alzheimers disease, neuroplasticity, immune response, and reproductive endocrine systems.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.45
- Field percentile
- top 39%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Convergent Pathways Identified for Cannabis Use Disorder Across Diverse Ancestry Populations
Qian Peng, Kirk C. Wilhelmsen, Cindy L. Ehlers·medRxiv·Mar 16, 2025
- Disentangling the shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD
Trine Tollerup Nielsen, Jinjie Duan, … Ditte Demontis·medRxiv·Feb 22, 2024
- Genome-wide association study implicates CHRNA2 in cannabis use disorder
Ditte Demontis, Veera Manikandan Rajagopal, … Anders Dupont Børglum·European NeuropsychopharmacologyPeer-reviewed·Jan 1, 2019
- Genome-wide association studies of lifetime and frequency cannabis use in 131,895 individuals
Hayley H. A. Thorpe, Pierre Fontanillas, … Sandra Sanchez‐Roige·Molecular PsychiatryPeer-reviewed·Oct 12, 2025
- Genome-wide association analysis of lifetime cannabis use (N=184,765) identifies new risk loci, genetic overlap with mental health, and a causal influence of schizophrenia on cannabis use
Joëlle A. Pasman, Karin J. H. Verweij, … Jacqueline M. Vink·bioRxiv·Jan 8, 2018
- Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking
Emma C. Johnson, Isabelle Austin-Zimmerman, … Arpana Agrawal A·NeuropsychopharmacologyPeer-reviewed·Jun 21, 2024